Prognostic Value of Circulating MG53 Levels in Acute Myocardial Infarction
Background: Mitsugumin 53 (MG53), a muscle-specific protein belonging to the TRIM family, has been demonstrated to protect the heart against oxidative injury. Although previous studies indicated that ischemic hearts released MG53 into circulation in mice, its effects in humans remains unknown. We ai...
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2020-10-01
|
| Series: | Frontiers in Cardiovascular Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2020.596107/full |
| _version_ | 1818890525063774208 |
|---|---|
| author | Hongyang Xie Hongyang Xie Zijun Yan Shuo Feng Tianqi Zhu Zhengbin Zhu Jingwei Ni Jun Ni Run Du Jinzhou Zhu Fenghua Ding Shengjun Liu Hui Han Hang Zhang Jiaxin Zhao Ruiyan Zhang Weiwei Quan Xiaoxiang Yan Xiaoxiang Yan |
| author_facet | Hongyang Xie Hongyang Xie Zijun Yan Shuo Feng Tianqi Zhu Zhengbin Zhu Jingwei Ni Jun Ni Run Du Jinzhou Zhu Fenghua Ding Shengjun Liu Hui Han Hang Zhang Jiaxin Zhao Ruiyan Zhang Weiwei Quan Xiaoxiang Yan Xiaoxiang Yan |
| author_sort | Hongyang Xie |
| collection | DOAJ |
| description | Background: Mitsugumin 53 (MG53), a muscle-specific protein belonging to the TRIM family, has been demonstrated to protect the heart against oxidative injury. Although previous studies indicated that ischemic hearts released MG53 into circulation in mice, its effects in humans remains unknown. We aimed to evaluate the prognostic value of MG53 in patients with ST-segment elevation myocardial infarction (STEMI).Methods: Serum levels of MG53 were measured in 300 patients with STEMI, all patients were followed for 3 years. The primary endpoint was major adverse cardiovascular events (MACE), defined as a composite of cardiovascular (CV) death, heart failure causing-rehospitalization, recurrent myocardial infarction (MI), and stroke.Results: Patients with a higher concentration of serum MG53 tended to be older, with a history of diabetes. MG53 levels were also highly associated with indicators reflecting heart function, such as left ventricular ejection fraction (LVEF), N terminal pro B type natriuretic peptide (NT-pro-BNP), and cardiac troponin I (cTnI) at baseline. Kaplan-Meier survival curves demonstrated that patients with MG53 levels above the cutoff value (132.17 pg/ml) were more likely to have MACEs. Moreover, it was found to be a significant predictor of CV death (HR: 6.12; 95% CI: 2.10–17.86; p = 0.001). Furthermore, the C-statistic and Integrated Discrimination Improvement (IDI) values for MACEs were improved with MG53 as an independent risk factor or when combined with cTnI.Conclusions: MG53 is a valuable prognostic marker of MACE in patients with AMI, independent of established conventional risk factors, highlighting the significance of MG53 in risk stratification post-MI. |
| first_indexed | 2024-12-19T17:26:18Z |
| format | Article |
| id | doaj.art-0c879b0e67e947aa934d1d8d9696ee0f |
| institution | Directory Open Access Journal |
| issn | 2297-055X |
| language | English |
| last_indexed | 2024-12-19T17:26:18Z |
| publishDate | 2020-10-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Cardiovascular Medicine |
| spelling | doaj.art-0c879b0e67e947aa934d1d8d9696ee0f2022-12-21T20:12:33ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2020-10-01710.3389/fcvm.2020.596107596107Prognostic Value of Circulating MG53 Levels in Acute Myocardial InfarctionHongyang Xie0Hongyang Xie1Zijun Yan2Shuo Feng3Tianqi Zhu4Zhengbin Zhu5Jingwei Ni6Jun Ni7Run Du8Jinzhou Zhu9Fenghua Ding10Shengjun Liu11Hui Han12Hang Zhang13Jiaxin Zhao14Ruiyan Zhang15Weiwei Quan16Xiaoxiang Yan17Xiaoxiang Yan18Department of Vascular & Cardiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaInstitute of Cardiovascular Diseases, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Vascular & Cardiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Vascular & Cardiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Vascular & Cardiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Vascular & Cardiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Vascular & Cardiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Vascular & Cardiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Vascular & Cardiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Vascular & Cardiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Vascular & Cardiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Vascular & Cardiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Vascular & Cardiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Vascular & Cardiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Vascular & Cardiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Vascular & Cardiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Vascular & Cardiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Vascular & Cardiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaInstitute of Cardiovascular Diseases, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaBackground: Mitsugumin 53 (MG53), a muscle-specific protein belonging to the TRIM family, has been demonstrated to protect the heart against oxidative injury. Although previous studies indicated that ischemic hearts released MG53 into circulation in mice, its effects in humans remains unknown. We aimed to evaluate the prognostic value of MG53 in patients with ST-segment elevation myocardial infarction (STEMI).Methods: Serum levels of MG53 were measured in 300 patients with STEMI, all patients were followed for 3 years. The primary endpoint was major adverse cardiovascular events (MACE), defined as a composite of cardiovascular (CV) death, heart failure causing-rehospitalization, recurrent myocardial infarction (MI), and stroke.Results: Patients with a higher concentration of serum MG53 tended to be older, with a history of diabetes. MG53 levels were also highly associated with indicators reflecting heart function, such as left ventricular ejection fraction (LVEF), N terminal pro B type natriuretic peptide (NT-pro-BNP), and cardiac troponin I (cTnI) at baseline. Kaplan-Meier survival curves demonstrated that patients with MG53 levels above the cutoff value (132.17 pg/ml) were more likely to have MACEs. Moreover, it was found to be a significant predictor of CV death (HR: 6.12; 95% CI: 2.10–17.86; p = 0.001). Furthermore, the C-statistic and Integrated Discrimination Improvement (IDI) values for MACEs were improved with MG53 as an independent risk factor or when combined with cTnI.Conclusions: MG53 is a valuable prognostic marker of MACE in patients with AMI, independent of established conventional risk factors, highlighting the significance of MG53 in risk stratification post-MI.https://www.frontiersin.org/articles/10.3389/fcvm.2020.596107/fullacute myocardial infarctionrisk stratificationbiomarkerprognosisMG53 |
| spellingShingle | Hongyang Xie Hongyang Xie Zijun Yan Shuo Feng Tianqi Zhu Zhengbin Zhu Jingwei Ni Jun Ni Run Du Jinzhou Zhu Fenghua Ding Shengjun Liu Hui Han Hang Zhang Jiaxin Zhao Ruiyan Zhang Weiwei Quan Xiaoxiang Yan Xiaoxiang Yan Prognostic Value of Circulating MG53 Levels in Acute Myocardial Infarction Frontiers in Cardiovascular Medicine acute myocardial infarction risk stratification biomarker prognosis MG53 |
| title | Prognostic Value of Circulating MG53 Levels in Acute Myocardial Infarction |
| title_full | Prognostic Value of Circulating MG53 Levels in Acute Myocardial Infarction |
| title_fullStr | Prognostic Value of Circulating MG53 Levels in Acute Myocardial Infarction |
| title_full_unstemmed | Prognostic Value of Circulating MG53 Levels in Acute Myocardial Infarction |
| title_short | Prognostic Value of Circulating MG53 Levels in Acute Myocardial Infarction |
| title_sort | prognostic value of circulating mg53 levels in acute myocardial infarction |
| topic | acute myocardial infarction risk stratification biomarker prognosis MG53 |
| url | https://www.frontiersin.org/articles/10.3389/fcvm.2020.596107/full |
| work_keys_str_mv | AT hongyangxie prognosticvalueofcirculatingmg53levelsinacutemyocardialinfarction AT hongyangxie prognosticvalueofcirculatingmg53levelsinacutemyocardialinfarction AT zijunyan prognosticvalueofcirculatingmg53levelsinacutemyocardialinfarction AT shuofeng prognosticvalueofcirculatingmg53levelsinacutemyocardialinfarction AT tianqizhu prognosticvalueofcirculatingmg53levelsinacutemyocardialinfarction AT zhengbinzhu prognosticvalueofcirculatingmg53levelsinacutemyocardialinfarction AT jingweini prognosticvalueofcirculatingmg53levelsinacutemyocardialinfarction AT junni prognosticvalueofcirculatingmg53levelsinacutemyocardialinfarction AT rundu prognosticvalueofcirculatingmg53levelsinacutemyocardialinfarction AT jinzhouzhu prognosticvalueofcirculatingmg53levelsinacutemyocardialinfarction AT fenghuading prognosticvalueofcirculatingmg53levelsinacutemyocardialinfarction AT shengjunliu prognosticvalueofcirculatingmg53levelsinacutemyocardialinfarction AT huihan prognosticvalueofcirculatingmg53levelsinacutemyocardialinfarction AT hangzhang prognosticvalueofcirculatingmg53levelsinacutemyocardialinfarction AT jiaxinzhao prognosticvalueofcirculatingmg53levelsinacutemyocardialinfarction AT ruiyanzhang prognosticvalueofcirculatingmg53levelsinacutemyocardialinfarction AT weiweiquan prognosticvalueofcirculatingmg53levelsinacutemyocardialinfarction AT xiaoxiangyan prognosticvalueofcirculatingmg53levelsinacutemyocardialinfarction AT xiaoxiangyan prognosticvalueofcirculatingmg53levelsinacutemyocardialinfarction |